Dr Katarzyna Jarus-Dziedzic Joins the Faculty of Andrzej Frycz Modrzewski Krakow University

We are proud to announce that BRG’s Principal Investigator and Managing Director, Dr Katarzyna Jarus-Dziedzic, has been invited to join the faculty of the postgraduate program at Andrzej Frycz Modrzewski Krakow University. This distinction highlights the broad recognition her expertise receives within the clinical research community and further strengthens BRG’s position as a trusted expert centre in early-phase studies.

Dr Jarus-Dziedzic will be teaching within the postgraduate program titled
“Practical Aspects of Conducting Clinical Trials – Methodology, Organisation, Management and Monitoring,”
bringing to the classroom not only extensive theoretical knowledge, but above all practical, real-world experience gained over more than 25 years in the field of clinical research. Throughout her career, she has served as a leader and medical expert in over 300 clinical studies, covering early-phase trials, bioequivalence and bioavailability research, as well as complex oncology and hematology projects carried out both in Poland and internationally.

Her work spans close collaboration with global pharmaceutical companies, CRO partners, scientific committees and regulatory stakeholders, giving her a uniquely multidimensional understanding of clinical development. Known for combining scientific rigor with hands-on operational insight, Dr Jarus-Dziedzic brings a wealth of case-based knowledge, best practices and strategic perspectives. Her ability to translate advanced scientific and regulatory concepts into actionable guidance has made her a valued mentor for professionals entering or advancing within the clinical research field.

As a seasoned practitioner, educator and contributor to scientific advancement, Dr Jarus-Dziedzic embodies BRG’s commitment to excellence, quality and continuous professional development. Her involvement in the postgraduate program reflects the natural alignment between BRG’s mission and the growing demand for well-trained specialists capable of navigating the complexities of modern clinical trials.

More information about the postgraduate program is available here:
https://podyplomowe.uafm.edu.pl/oferta/praktyczne-aspekty-prowadzenia-badan-klinicznych-metodologia-organizacja-zarzadzanie-i-monitorowanie/

Go back

News

Clinical research reshapes nicotine regulation - BRG article in ITJ

upcoming publication by Dr. Katarzyna Jarus-Dziedzic, on the increasing importance of clinical studies in the Tobacco Market

Read more …

Data Quality at the Center of Regulatory Attention – the BRG Standard

In recent months, regulators have placed an even stronger emphasis on data quality in clinical trials.

Read more …

Regulatory change across the European Union

Flavoured heated tobacco (HnB) sticks withdrawn from sale as of 18 January 2025

Read more …

Novel Nicotine Products Under Increasing Regulatory Pressure. Safety Studies Become a Key Pillar

Novel Nicotine Products Under Increasing Regulatory Pressure. Safety Studies Become a Key Pillar of Market Authorization

Read more …

About Us | Services | Our Site | Partners | Smoking Risk Study | Contact Us

Early Phase Clinical Trials

2026 © Bio Research Group. All rights reserved.

 

scroll to top ▲